Fundraising Fox

IO Biotech

8 known investors

iobiotech.com ↗

The page presents a biography of Dr. Dhingra, a medical oncologist and physician-scientist with experience in oncology drug development. It provides no clear description of the company's own products or services.

Biotech

Investors · 8

Avoro Capital AdvisorsNew York
EIR VenturesStockholm
Kurma PartnersParis · $162K – $10.8M
RA CapitalBoston
Sunstone CapitalFrederiksberg
Vivo CapitalPalo Alto · $10M – $50M
European Investment BankreportedLuxembourg
HBM Healthcare InvestmentsreportedZug

In the news

The rollercoaster ride stopps and danish IO Biotech goes bust - European Biotechnology Magazineeuropean-biotechnology.com · Apr 2026IO Biotech secures up to €57.5 million in debt financing from the European Investment Bankglobenewswire.com · Dec 2024Avoro Capital Advisors | Newsavorocapital.com · Jun 2021IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncologyprnewswire.com · Jan 2021IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines | Fierce Biotechfiercebiotech.com · Jan 2021IO Biotech Announces 2023 Fourth-Quarter and Year-End Resultsstreetinsider.com

Frequently asked questions

What does IO Biotech do?
The page presents a biography of Dr. Dhingra, a medical oncologist and physician-scientist with experience in oncology drug development. It provides no clear description of the company's own products or services.
Who are IO Biotech's investors?
IO Biotech's investors include Avoro Capital Advisors, EIR Ventures, Kurma Partners, RA Capital, Sunstone Capital, Vivo Capital, European Investment Bank, HBM Healthcare Investments.